ZLAB - Zai Lab Ltd

Insider Sale by Edmondson Frazor Titus III (GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Edmondson Frazor Titus III, serving as GC at Zai Lab Ltd (ZLAB), sold 4,194 shares at $20.39 per share, for a total transaction value of $85,516.00. Following this transaction, Edmondson Frazor Titus III now holds 24,590 shares of ZLAB.

This sale represents a 15.00% decrease in Edmondson Frazor Titus III's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 1 day after the trade was made.

Zai Lab Ltd operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Edmondson Frazor Titus III

GC

Edmondson Frazor Titus III, also known as F. Ty Edmondson, J.D., is the Chief Legal Officer and Corporate Secretary at Zai Lab Ltd (ZLAB), a position he has held since joining the company in August 2020.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/) In this role, he oversees the company's legal, compliance, and sustainability functions.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/) He recently reported the sale of 8,651 shares of Zai Lab Ltd on December 16, 2025, as per SEC Form 144 filings.[[2]](https://www.otcmarkets.com/filing/conv_pdf?id=18998666&guid=-wt-kKC9-DtRB3h)[[3]](https://www.gurufocus.com/news/4077153/insider-sell-edmondson-frazor-titus-iii-sells-8651-shares-of-zai-lab-ltd-zlab?mobile=true) Edmondson brings extensive experience in legal and compliance within the life sciences industry. Prior to Zai Lab, he worked at Biogen from June 2014 to August 2020, most recently as Senior Vice President, Chief Corporate Counsel, and Assistant Secretary, and previously as Chief Compliance Officer and Chief Commercial Counsel.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/) Earlier, he served as Vice President, Associate General Counsel, and Corporate Secretary at Sepracor, Inc., followed by senior legal roles in Japan and China after its acquisition by Sumitomo Dainippon Pharma.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/) His career also includes positions at Eisai, Inc., Boston Scientific, and Bristol-Myers Squibb, focusing on international and U.S. FDA matters, and he began as an associate at Royston Rayzor in Houston, Texas.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/) He holds a J.D. from Widener University School of Law and graduated from Washington & Lee University.[[5]](https://www.zailaboratory.com/leadership/f-ty-edmondson/)

View full insider profile →

Trade Price

$20.39

Quantity

4,194

Total Value

$85,516.00

Shares Owned

24,590

Trade Date

Thursday, April 2, 2026

2 days ago

SEC Filing Date

Friday, April 3, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Zai Lab Ltd

Company Overview

No company information available
View news mentioning ZLAB

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5335955

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime